Sous-vide launch without product-specific validation
A chilled ready-meal factory plans to launch a new sous-vide chicken product. The process uses 62 °C for 45 minutes, then rapid chilling to 3 °C within 90 minutes. The food safety team has a validation report for a similar chicken breast cooked at 65 °C for 30 minutes on a different line. They propose to use the same report because the new product is cooked “longer”. The new product also uses a modified atmosphere pack (30% CO2/70% N2) from a new supplier. The first production run of 4,800 packs is scheduled for Monday. The technical manager says validation can be completed after the first run because the product will be held for 7 days and tested for Listeria. The site has no challenge-testing capability and relies on published literature. The customer requires a 10-day shelf life and absence of Listeria monocytogenes in 25 g. The site’s hazard analysis lists L. monocytogenes as a significant hazard and cooling as a CCP.
1. Evaluate whether the 65 °C/30 min validation report can support the new 62 °C/45 min process. What evidence is needed before the control measure is used in routine production?
Read the worked answer
The 65 °C/30 min report cannot be assumed to validate 62 °C/45 min. Lethality depends on both temperature and time, and the product matrix, thickness, load and line differ. A lower temperature is not automatically compensated by a longer time without evidence.
The team needs a documented validation showing that the new process achieves the required reduction of L. monocytogenes and other target organisms for this specific product. Acceptable sources can include matched published scientific literature, regulatory guidance or challenge tests. The literature must match the product’s pH, water activity, fat, salt, thickness and packaging atmosphere. The cooling step also needs validation: 3 °C within 90 minutes must be demonstrated at the cold spot of the packs, not just the air temperature.
Validation must be completed before the control measure is applied in routine production, unless product is fully segregated and not released. A 7-day end-product test is verification, not validation, and a negative test does not prove the process is capable because of sampling limitations.
2. Can the first run of 4,800 packs proceed on Monday? State the conditions under which production or a trial could occur.
Read the worked answer
The first run should not be released to the customer on the current plan. The technical manager’s proposal inverts the order: validation must precede routine production, and end-product testing is weak verification.
Options are: postpone until validation is complete; run as a trial with all 4,800 packs quarantined and used only for validation and verification sampling; or, if the team can justify the process from robust matched literature, run with full segregation and positive release after validation and verification. In each case, define the hold, sampling plan (cold-spot temperature, Listeria testing, gas composition), acceptance criteria, and who authorises release.
The new gas mix and supplier also need attention. CO2/N2 affects Listeria growth and pack integrity; supplier approval and a certificate of analysis are not validation of the product’s safety. The trial should include shelf-life testing at 4 °C and an abuse temperature such as 8 °C.
3. Describe the verification and supplier-control activities needed after the process is validated.
Read the worked answer
Verification should include temperature profiles of the cook and chiller at a defined frequency, pack gas analysis, seal integrity checks, shelf-life testing, environmental monitoring and record review. The team should confirm that the validated cold-spot conditions are reproduced in the actual racks or crates, not only in the trial sample.
For the new gas supplier, apply the external provider control requirements: approve the supplier, define the specification and certificate of analysis, verify incoming gas composition and cylinder identity, and monitor performance. Supplier approval does not replace product validation.
Verification results must be reviewed and used to update the hazard analysis and hazard control plan. If verification shows the process is drifting outside the validated conditions, the team must treat it as a nonconformity and assess affected product, not just adjust the records.